Compare SPRY & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SPRY | DAVE |
|---|---|---|
| Founded | 2015 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 3.1B |
| IPO Year | N/A | N/A |
| Metric | SPRY | DAVE |
|---|---|---|
| Price | $10.82 | $193.81 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 6 |
| Target Price | $35.00 | ★ $282.17 |
| AVG Volume (30 Days) | ★ 1.8M | 475.4K |
| Earning Date | 11-10-2025 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 224.46 |
| EPS | N/A | ★ 10.12 |
| Revenue | $142,772,000.00 | ★ $491,301,000.00 |
| Revenue This Year | N/A | $56.88 |
| Revenue Next Year | $123.33 | $18.07 |
| P/E Ratio | ★ N/A | $19.17 |
| Revenue Growth | ★ 5459.66 | 53.84 |
| 52 Week Low | $6.66 | $65.46 |
| 52 Week High | $18.90 | $286.45 |
| Indicator | SPRY | DAVE |
|---|---|---|
| Relative Strength Index (RSI) | 47.57 | 39.59 |
| Support Level | $10.76 | $179.00 |
| Resistance Level | $11.93 | $250.50 |
| Average True Range (ATR) | 0.67 | 14.50 |
| MACD | -0.13 | -4.54 |
| Stochastic Oscillator | 0.58 | 22.45 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.